The second interim dividend will be paid no later than 3 months from the date of declaration pursuant to Paragraph 8.26 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad.
On the same day, Mercury Securities Sdn. Bhd, on behalf of the Board of Directors of Duopharma Biotech announced that the issue price of the new ordinary shares in Duopharma Biotech (“Duopharma Biotech Shares”) to be issued pursuant to the DRP has been fixed (“Price Fixing Date”) at RM3.08 per new Duopharma Biotech Share.
The issue price is computed based on the 5-day volume weighted average market price of Duopharma Biotech Shares (“VWAMP”) up to 19 February 2021, being the last trading day prior to the Price Fixing Date of RM3.48 after adjusting for the following:
(i) single-tier second interim dividend of RM0.06 per Duopharma Biotech Share; and
(ii) a discount of approximately 10% to the 5-day ex-dividend VWAMP of RM3.42.